Cargando…
Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy
Bone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in experimental animal models of ischemic myocardial injury. With scanty evidence regarding their cardiogenic differentiation in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953131/ https://www.ncbi.nlm.nih.gov/pubmed/31918755 http://dx.doi.org/10.1186/s13287-019-1548-7 |